Ariel Werman

2.5k total citations · 2 hit papers
14 papers, 2.0k citations indexed

About

Ariel Werman is a scholar working on Immunology, Epidemiology and Molecular Biology. According to data from OpenAlex, Ariel Werman has authored 14 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 4 papers in Epidemiology and 3 papers in Molecular Biology. Recurrent topics in Ariel Werman's work include Immune Response and Inflammation (3 papers), Endoplasmic Reticulum Stress and Disease (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Ariel Werman is often cited by papers focused on Immune Response and Inflammation (3 papers), Endoplasmic Reticulum Stress and Disease (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Ariel Werman collaborates with scholars based in United States, Israel and Japan. Ariel Werman's co-authors include Antonio Vidal‐Puig, Menachem Rubinstein, Daniela Novick, J S Flier, Walter J. Pories, Mercedes Jimenez‐Liñan, Robert V. Considine, Sara Barak, Charles A. Dinarello and Gemma Solanes and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Ariel Werman

14 papers receiving 2.0k citations

Hit Papers

Peroxisome proliferator-activated receptor gene expressio... 1997 2026 2006 2016 1997 2013 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids.
    1997 663 citations Antonio Vidal‐Puig, Robert V. Considine et al. Journal of Clinical Investigation profile →
  2. LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus
    2013 454 citations Ariel Werman, Daniela Novick et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ariel Werman United States 11 1.2k 548 487 429 311 14 2.0k
Lyoung Hyo Kim South Korea 28 697 0.6× 420 0.8× 388 0.8× 421 1.0× 437 1.4× 73 2.0k
Naveenan Navaratnam United Kingdom 27 2.0k 1.7× 265 0.5× 402 0.8× 571 1.3× 210 0.7× 43 2.8k
José María González Spain 28 1.4k 1.1× 207 0.4× 725 1.5× 282 0.7× 362 1.2× 82 2.9k
Mingcan Yu United States 21 1.1k 0.9× 262 0.5× 762 1.6× 184 0.4× 222 0.7× 34 2.1k
G P Jahreis United States 21 796 0.7× 228 0.4× 482 1.0× 298 0.7× 187 0.6× 29 2.0k
Brooks Scull United States 16 595 0.5× 486 0.9× 256 0.5× 223 0.5× 223 0.7× 28 1.3k
Mary Ann Suico Japan 26 1.1k 0.9× 274 0.5× 460 0.9× 227 0.5× 96 0.3× 109 2.1k
Ganesh Kolumam United States 26 788 0.7× 349 0.6× 1.5k 3.0× 490 1.1× 215 0.7× 37 2.9k
Fabienne Andris Belgium 23 645 0.5× 348 0.6× 980 2.0× 568 1.3× 115 0.4× 52 2.4k
Anton T. J. Tool Netherlands 30 650 0.5× 460 0.8× 1.5k 3.1× 468 1.1× 373 1.2× 67 2.9k

Countries citing papers authored by Ariel Werman

Since Specialization
Citations

This map shows the geographic impact of Ariel Werman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ariel Werman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ariel Werman more than expected).

Fields of papers citing papers by Ariel Werman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ariel Werman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ariel Werman. The network helps show where Ariel Werman may publish in the future.

Co-authorship network of co-authors of Ariel Werman

This figure shows the co-authorship network connecting the top 25 collaborators of Ariel Werman. A scholar is included among the top collaborators of Ariel Werman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ariel Werman. Ariel Werman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Werman, Ariel, et al.. (2013). LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus. Proceedings of the National Academy of Sciences. 110(18). 7306–7311. 454 indexed citations breakdown →
2.
Werman, Ariel, et al.. (2010). C/EBP-β Regulates Endoplasmic Reticulum Stress–Triggered Cell Death in Mouse and Human Models. PLoS ONE. 5(3). e9516–e9516. 47 indexed citations
3.
4.
Werman, Ariel, et al.. (2008). 268 A role for intra-cellular interleukin-1alpha in antiviral defense. Cytokine. 43(3). 307–307. 2 indexed citations
5.
Novick, Daniela, et al.. (2007). Antiviral and immunoregulatory activities of IFN-γ depend on constitutively expressed IL-1α. Proceedings of the National Academy of Sciences. 104(12). 5044–5049. 47 indexed citations
6.
Novick, Daniela, et al.. (2007). 59 Antiviral and Immunoregulatory Activities of IFN-gamma Depend on Constitutively Expressed IL-1 alpha. Cytokine. 39(1). 17–17. 16 indexed citations
7.
Kamari, Yehuda, Aviv Shaish, Ariel Werman, et al.. (2006). Differential role and tissue specificity of interleukin-1α gene expression in atherogenesis and lipid metabolism. Atherosclerosis. 195(1). 31–38. 90 indexed citations
8.
Reznikov, Leonid L., Joel Waksman, Tania Azam, et al.. (2004). Effect of advanced glycation end products on endotoxin-induced TNF-a, IL-1b and IL-8 in human peripheral blood mononuclear cells. Clinical Nephrology. 61(5). 324–336. 44 indexed citations
9.
Werman, Ariel, Rosalyn M. White, Yakov Krelin, et al.. (2004). The precursor form of IL-1α is an intracrine proinflammatory activator of transcription. Proceedings of the National Academy of Sciences. 101(8). 2434–2439. 293 indexed citations
10.
Dvorkin, Tatyana, Eyal Fima, Yakov Krelin, et al.. (2000). Opposing effects of IL-1 alpha and IL-1 beta on malignancy patterns. Tumor cell-associated IL-1 alpha potentiates anti-tumor immune responses and tumor regression, whereas IL-1 beta potentiates invasiveness.. PubMed. 479. 277–88. 28 indexed citations
11.
Apte, Ron N., Tatyana Dvorkin, Eyal Fima, et al.. (2000). OPPOSING EFFECTS OF IL-l AND IL-1 ON MALIGNANCY PATTERNS Tumor cell-associated IL- I potentiates anti-tumor immune responses and tumor regression, whereas IL- 1 potentiates invasiveness. 5 indexed citations
12.
Selzman, Craig H., Brian D. Shames, Leonid L. Reznikov, et al.. (1999). Liposomal Delivery of Purified Inhibitory-κBα Inhibits Tumor Necrosis Factor-α–Induced Human Vascular Smooth Muscle Proliferation. Circulation Research. 84(8). 867–875. 70 indexed citations
13.
Werman, Ariel, Anthony N. Hollenberg, Gemma Solanes, et al.. (1997). Ligand-independent Activation Domain in the N Terminus of Peroxisome Proliferator-activated Receptor γ (PPARγ). Journal of Biological Chemistry. 272(32). 20230–20235. 252 indexed citations
14.
Vidal‐Puig, Antonio, Robert V. Considine, Mercedes Jimenez‐Liñan, et al.. (1997). Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids.. Journal of Clinical Investigation. 99(10). 2416–2422. 663 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lyoung Hyo Kim Breakdown of academic impact, for papers by Naveenan Navaratnam Breakdown of academic impact, for papers by José María González Breakdown of academic impact, for papers by Mingcan Yu Breakdown of academic impact, for papers by G P Jahreis Breakdown of academic impact, for papers by Brooks Scull Breakdown of academic impact, for papers by Mary Ann Suico Breakdown of academic impact, for papers by Ganesh Kolumam Breakdown of academic impact, for papers by Fabienne Andris Breakdown of academic impact, for papers by Anton T. J. Tool
Rankless by CCL
2026